Covington & Burling advised an affiliate of OrbiMed Advisors on the transaction. OrbiMed Advisors announced its agreement to purchase 100% of Neurelis Inc.’s rights, royalty interests,...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Insmed Incorporated on the transaction. Insmed Incorporated (Nasdaq: INSM) (“Insmed”) announced its entrance into an agreement to amend its $350 million term...
You must be a Standard 1 Year member to access this content.
King & Spalding advised the syndicate of Joint Lead Managers on the offering. Telekom Srbija a.d. Beograd completed its $900 million senior notes offering, representing the...
You must be a Standard 1 Year member to access this content.
OrbiMed was advised by LPA-CGR, BCLP, and Covington & Burling. Dechert LLP (Paris and New York) advised Poxel. OrbiMed announced it has entered into a non-dilutive...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised Omeros Corporation on the deal, and King & Spalding and Paul Hastings represented the lenders. Omeros Corporation (Omeros) (Nasdaq: OMER) announced it...
You must be a Standard 1 Year member to access this content.
Covington & Burling represented OrbiMed Advisors, LLC in the transaction. OrbiMed Advisors, LLC, a healthcare investment firm, announced a debt financing facility for up to $50...
You must be a Standard 1 Year member to access this content.
Ropes & Gray has advised Altice USA, while Paul Hastings LLP advised Goldman Sachs. Altice USA (NYSE:ATUS) issued $2.05 billion Senior Guaranteed Notes due 2029 by its...
You must be a Standard 1 Year member to access this content.
Paul Hastings (Europe) LLP advised the dealer managers in connection with the tender offer. Helios Towers plc announced that USD 325 million aggregate principal of the...
You must be a Standard 1 Year member to access this content.
Paul Hastings (Europe) LLP advised the arrangers and lenders in connection with the refinancing. Helios Towers plc, the independent telecommunications infrastructure company, has secured new debt facilities worth...
You must be a Standard 1 Year member to access this content.
Covington & Burling advised OrbiMed on the deal. OrbiMed announced its $125 million debt financing with Verrica Pharmaceuticals, a dermatology therapeutics company developing medications for skin diseases...
You must be a Standard 1 Year member to access this content.
Covington advised Eisai in the transaction. Eisai Co., Ltd. signed its agreement to transfer all future economic rights for elacestrant (generic name), approved for the treatment for...
You must be a Standard 1 Year member to access this content.
Covington advised Humacyte on the deal. Humacyte, Inc. announced its $150 million revenue-based funding arrangement, as well as a $10 million equity investment option, with Oberland...
You must be a Standard 1 Year member to access this content.
